127 related articles for article (PubMed ID: 37170656)
21. Association Between Choice of Radical Prostatectomy, External Beam Radiotherapy, Brachytherapy, or Active Surveillance and Patient-Reported Quality of Life Among Men With Localized Prostate Cancer.
Chen RC; Basak R; Meyer AM; Kuo TM; Carpenter WR; Agans RP; Broughman JR; Reeve BB; Nielsen ME; Usinger DS; Spearman KC; Walden S; Kaleel D; Anderson M; Stürmer T; Godley PA
JAMA; 2017 Mar; 317(11):1141-1150. PubMed ID: 28324092
[TBL] [Abstract][Full Text] [Related]
22. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy.
Lilleby W; Fosså SD; Waehre HR; Olsen DR
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):735-43. PubMed ID: 10098428
[TBL] [Abstract][Full Text] [Related]
23. Is the Toxicity of Salvage Prostatectomy Related to the Primary Prostate Cancer Therapy Received?
Ribeiro L; Stonier T; Stroman L; Tourinho-Barbosa R; Alghazo O; Winkler M; Dasgupta P; Popert R; Cathelineau X; Sanchez-Salas R; Murphy DG; Emberton M; Cathcart P
J Urol; 2021 Mar; 205(3):791-799. PubMed ID: 33021441
[TBL] [Abstract][Full Text] [Related]
24. Surgeon heterogeneity significantly affects functional and oncological outcomes after radical prostatectomy in the Swedish LAPPRO trial.
Nyberg M; Sjoberg DD; Carlsson SV; Wilderäng U; Carlsson S; Stranne J; Wiklund P; Steineck G; Haglind E; Hugosson J; Bjartell A
BJU Int; 2021 Mar; 127(3):361-368. PubMed ID: 32916021
[TBL] [Abstract][Full Text] [Related]
25. Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy - an ancillary study of the SAKK 09/10 randomized clinical trial.
Dal Pra A; Ghadjar P; Hayoz S; Liu VYT; Spratt DE; Thompson DJS; Davicioni E; Huang HC; Zhao X; Liu Y; Schär C; Gut P; Plasswilm L; Hölscher T; Polat B; Hildebrandt G; Müller AC; Pollack A; Thalmann GN; Zwahlen D; Aebersold DM
Ann Oncol; 2022 Sep; 33(9):950-958. PubMed ID: 35636621
[TBL] [Abstract][Full Text] [Related]
26. Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy.
Trock BJ; Han M; Freedland SJ; Humphreys EB; DeWeese TL; Partin AW; Walsh PC
JAMA; 2008 Jun; 299(23):2760-9. PubMed ID: 18560003
[TBL] [Abstract][Full Text] [Related]
27. Salvage radical prostatectomy as management of locally recurrent prostate cancer: outcomes and complications.
Rosoff JS; Savage SJ; Prasad SM
World J Urol; 2013 Dec; 31(6):1347-52. PubMed ID: 23358790
[TBL] [Abstract][Full Text] [Related]
28. The Effect of Salvage Radiotherapy and its Timing on the Health-related Quality of Life of Prostate Cancer Patients.
van Stam MA; Aaronson NK; Pos FJ; Bosch JL; Kieffer JM; Tillier CN; van der Poel HG
Eur Urol; 2016 Nov; 70(5):751-757. PubMed ID: 27016464
[TBL] [Abstract][Full Text] [Related]
29. Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years.
Barocas DA; Alvarez J; Resnick MJ; Koyama T; Hoffman KE; Tyson MD; Conwill R; McCollum D; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Kaplan SH; Paddock LE; Stroup AM; Wu XC; Penson DF
JAMA; 2017 Mar; 317(11):1126-1140. PubMed ID: 28324093
[TBL] [Abstract][Full Text] [Related]
30. Comparative Outcomes of Salvage Retzius-Sparing versus Standard Robotic Prostatectomy: An International, Multi-Surgeon Series.
Kowalczyk KJ; Madi RH; Eden CG; Sooriakumaran P; Fransis K; Raskin Y; Joniau S; Johnson S; Jacobsohn K; Galfano A; Bocciardi AM; Hwang J; Kim IY; Hu JC
J Urol; 2021 Nov; 206(5):1184-1191. PubMed ID: 34181471
[TBL] [Abstract][Full Text] [Related]
31. Prospective longitudinal outcomes of quality of life after laparoscopic radical prostatectomy compared with retropubic radical prostatectomy.
Hashine K; Kakuda T; Iuchi S; Hosokawa T; Ninomiya I
Health Qual Life Outcomes; 2018 Jan; 16(1):7. PubMed ID: 29304808
[TBL] [Abstract][Full Text] [Related]
32. Impact of timing on salvage radiation therapy adverse events following radical prostatectomy: A secondary analysis of the RTOG 9601 cohort.
Baumgarten L; Borchert A; Sood A; Dalela D; Arora S; Keeley J; Rogers C; Peabody J; Menon M; Abdollah F
Urol Oncol; 2020 Feb; 38(2):38.e17-38.e22. PubMed ID: 31653564
[TBL] [Abstract][Full Text] [Related]
33. Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series.
Fossati N; Karnes RJ; Boorjian SA; Moschini M; Morlacco A; Bossi A; Seisen T; Cozzarini C; Fiorino C; Noris Chiorda B; Gandaglia G; Dell'Oglio P; Joniau S; Tosco L; Shariat S; Goldner G; Hinkelbein W; Bartkowiak D; Haustermans K; Tombal B; Montorsi F; Van Poppel H; Wiegel T; Briganti A
Eur Urol; 2017 Jun; 71(6):886-893. PubMed ID: 27484843
[TBL] [Abstract][Full Text] [Related]
34. Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer.
Sanderson KM; Penson DF; Cai J; Groshen S; Stein JP; Lieskovsky G; Skinner DG
J Urol; 2006 Nov; 176(5):2025-31; discussion 2031-2. PubMed ID: 17070244
[TBL] [Abstract][Full Text] [Related]
35. Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients.
Cozzarini C; Fiorino C; Deantoni C; Briganti A; Fodor A; La Macchia M; Noris Chiorda B; Rancoita PM; Suardi N; Zerbetto F; Calandrino R; Montorsi F; Di Muzio N
Eur Urol; 2014 Dec; 66(6):1024-30. PubMed ID: 24985964
[TBL] [Abstract][Full Text] [Related]
36. Population-based study of long-term functional outcomes after prostate cancer treatment.
Carlsson S; Drevin L; Loeb S; Widmark A; Lissbrant IF; Robinson D; Johansson E; Stattin P; Fransson P
BJU Int; 2016 Jun; 117(6B):E36-45. PubMed ID: 25959859
[TBL] [Abstract][Full Text] [Related]
37. Oncological and functional outcomes 1 year after radical prostatectomy for very-low-risk prostate cancer: results from the prospective LAPPRO trial.
Carlsson S; Jäderling F; Wallerstedt A; Nyberg T; Stranne J; Thorsteinsdottir T; Carlsson SV; Bjartell A; Hugosson J; Haglind E; Steineck G
BJU Int; 2016 Aug; 118(2):205-12. PubMed ID: 26867018
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data.
Vale CL; Fisher D; Kneebone A; Parker C; Pearse M; Richaud P; Sargos P; Sydes MR; Brawley C; Brihoum M; Brown C; Chabaud S; Cook A; Forcat S; Fraser-Browne C; Latorzeff I; Parmar MKB; Tierney JF;
Lancet; 2020 Oct; 396(10260):1422-1431. PubMed ID: 33002431
[TBL] [Abstract][Full Text] [Related]
39. [Treatment results of salvage radiotherapy for biochemical recurrence after radical prostatectomy].
Hatano K; Kinouchi T; Kinoshita T; Kobayashi M; Inoue H; Takada T; Hara T
Nihon Hinyokika Gakkai Zasshi; 2009 Nov; 100(7):671-8. PubMed ID: 19999131
[TBL] [Abstract][Full Text] [Related]
40. Radiotherapy after radical prostatectomy: Effect of timing of postprostatectomy radiation on functional outcomes.
Huelster HL; Laviana AA; Joyce DD; Huang LC; Zhao Z; Koyama T; Hoffman KE; Conwill R; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg M; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Penson DF; Barocas DA
Urol Oncol; 2020 Dec; 38(12):930.e23-930.e32. PubMed ID: 32736934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
